IL‐17: A new actor in IFN‐driven systemic autoimmune diseases

No abstract is available for this paper.

• Publication year

  2012

• Venue

  European Journal of Immunology

• Publication date

  2012-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/eji.201242653PMID 22949326
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study.

  2012cited by this paper
• IL‐17‐producing γδ T cells and innate lymphoid cells

  2012cited by this paper
• Psoriasis: rationale for targeting interleukin‐17

  2012cited by this paper
• Regulation and function of mTOR signalling in T cell fate decisions

  2012cited by this paper
• Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation

  2011cited by this paper
• Interferon-β exacerbates Th17-mediated inflammatory disease.

  2011cited by this paper
• Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation.

  2011cited by this paper
• Type I interferon-dependent CD86(high) marginal zone precursor B cells are potent T cell costimulators in mice.

  2011cited by this paper
• Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and -negative rheumatoid arthritis and osteoarthritis synovium

  2011cited by this paper
• Impact of interleukin-21 in the pathogenesis of primary Sjogren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands

  2011cited by this paper
• The many faces of Th17 cells.

  2011cited by this paper
• Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study

  2011cited by this paper
• Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5

  2011cited by this paper
• Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with Systemic Lupus Erythematosus

  2011cited by this paper
• Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis

  2011cited by this paper
• The Dysregulation of Cytokine Networks in Systemic Lupus Erythematosus

  2011cited by this paper
• Copy number variations of interleukin-17F, interleukin-21, and interleukin-22 are associated with systemic lupus erythematosus.

  2011cited by this paper
• Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus.

  2010cited by this paper
• Plasma IL-17A Is Increased in New-Onset SLE Patients and Associated with Disease Activity

  2010cited by this paper
• Laser microdissection‐based analysis of cytokine balance in the kidneys of patients with lupus nephritis

  2010cited by this paper
• Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus

  2010cited by this paper
• Proinflammatory T helper type 17 cells are effective B-cell helpers

  2010cited by this paper
• Mast cells express IL-17A in rheumatoid arthritis synovium: Commentary

  2010cited by this paper
• Cutting Edge: IL-23 Receptor Deficiency Prevents the Development of Lupus Nephritis in C57BL/6–lpr/lpr Mice

  2010cited by this paper
• Generation of Pathogenic Th17 Cells in the Absence of TGF-β Signaling

  2010cited by this paper
• Recent advances in the genetics of systemic lupus erythematosus

  2010cited by this paper
• Innate IL-17-producing cells: the sentinels of the immune system

  2010cited by this paper
• Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study.

  2010cited by this paper
• Mast cells express IL-17A in rheumatoid arthritis synovium.

  2010cited by this paper
• T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis

  2010cited by this paper
• A Naturally Occurring, Soluble Antagonist of Human IL-23 Inhibits the Development and In Vitro Function of Human Th17 Cells

  2010cited by this paper
• Th17 cytokines and arthritis

  2010cited by this paper
• Innate IL-17-producing cells: the sentinels of the immune system

  2010cited by this paper
• Suppression of inflammation in ulcerative colitis by interferon-β-1a is accompanied by inhibition of IL-13 production

  2010cited by this paper
• Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus

  2010cited by this paper
• Th17 and natural Treg cell population dynamics in systemic lupus erythematosus.

  2009cited by this paper
• The Role of IL-23/IL-17 Axis in Lupus Nephritis1

  2009cited by this paper
• Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.

  2009cited by this paper
• A polymorphism within IL21R confers risk for systemic lupus erythematosus.

  2009cited by this paper
• The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus.

  2009cited by this paper
• IFN-β Inhibits Human Th17 Cell Differentiation1

  2009cited by this paper
• Human Dendritic Cells Stimulated via TLR7 and/or TLR8 Induce the Sequential Production of Il-10, IFN-γ, and IL-17A by Naive CD4+ T Cells

  2009cited by this paper
• A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice

  2009cited by this paper
• IL-17 and Th17 Cells.

  2009cited by this paper
• Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus

  2009cited by this paper
• Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23–Th17 pathway

  2009cited by this paper
• Association of Interleukin 23 Receptor Polymorphisms with Anti-Topoisomerase-I Positivity and Pulmonary Hypertension in Systemic Sclerosis

  2009cited by this paper
• The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17–producing effector T helper cells in vivo

  2009cited by this paper
• Vicious circle: systemic autoreactivity in Ro52/TRIM21-deficient mice

  2009cited by this paper
• Use of laser microdissection in the analysis of renal-infiltrating T cells in MRL/lpr mice

  2008cited by this paper
• Increased serum interleukin 23 in patients with systemic sclerosis.

  2008cited by this paper
• Interleukin 17–producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice

  2008cited by this paper
• The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype

  2008cited by this paper
• The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice.

  2008cited by this paper
• A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5

  2008cited by this paper
• Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice.

  2008cited by this paper
• Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys1

  2008cited by this paper
• Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis

  2008cited by this paper
• Targeting of the immune system in systemic lupus erythematosus

  2008cited by this paper
• Increased Serum Soluble OX40 in Patients with Systemic Sclerosis

  2008cited by this paper
• A fundamental role for interleukin-21 in the generation of T follicular helper cells.

  2008cited by this paper
• Cutaneous vasculitis in breast cancer treated with chemotherapy.

  2008cited by this paper
• Interleukin 21 as a target of intervention in autoimmune disease

  2008cited by this paper
• An overview of IL-17 function and signaling.

  2008cited by this paper
• Genomewide Scan Reveals Association of Psoriasis with IL-23 and NF-κB Pathways

  2008cited by this paper
• IL-21 Is Produced by Th17 Cells and Drives IL-17 Production in a STAT3-dependent Manner*

  2007cited by this paper
• Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus

  2007cited by this paper
• Association of an IRF5 gene functional polymorphism with Sjögren's syndrome.

  2007cited by this paper
• IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells

  2007cited by this paper
• Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis

  2007cited by this paper
• Low-Dose Peptide Tolerance Therapy of Lupus Generates Plasmacytoid Dendritic Cells That Cause Expansion of Autoantigen-Specific Regulatory T Cells and Contraction of Inflammatory Th17 Cells12

  2007cited by this paper
• Cutting Edge: An In Vivo Requirement for STAT3 Signaling in TH17 Development and TH17-Dependent Autoimmunity1

  2007cited by this paper
• IL-21 and BAFF/BLyS Synergize in Stimulating Plasma Cell Differentiation from a Unique Population of Human Splenic Memory B Cells1

  2007cited by this paper
• Murine Dendritic Cell Type I IFN Production Induced by Human IgG-RNA Immune Complexes Is IFN Regulatory Factor (IRF)5 and IRF7 Dependent and Is Required for IL-6 Production1

  2007cited by this paper
• Orphanet Journal of Rare Diseases BioMed Central Review

  2006cited by this paper
• A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus

  2006cited by this paper
• The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

  2006cited by this paper
• TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

  2006cited by this paper
• Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

  2006cited by this paper
• Complex modulation of cell type-specific signaling in response to type I interferons.

  2006cited by this paper
• Anti‐interleukin‐6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus

  2006cited by this paper
• Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome autoantigen-associated RNA.

  2006cited by this paper
• Control of B-cell responses by Toll-like receptors

  2005cited by this paper
• Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus1

  2005cited by this paper
• IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

  2005cited by this paper
• Cutting Edge: Role of STAT1, STAT3, and STAT5 in IFN-αβ Responses in T Lymphocytes

  2005cited by this paper
• Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.

  2005cited by this paper
• Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-alpha beta responses in T lymphocytes.

  2005cited by this paper
• Mechanisms of type-I- and type-II-interferon-mediated signalling

  2005cited by this paper
• Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors

  2005cited by this paper
• Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus.

  2005cited by this paper
• Genetic Segregation of Spontaneous Erosive Arthritis and Generalized Autoimmune Disease in the BXD2 Recombinant Inbred Strain of Mice

  2005cited by this paper
• The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

  2004cited by this paper
• Regulation of B Cell Differentiation and Plasma Cell Generation by IL-21, a Novel Inducer of Blimp-1 and Bcl-61

  2004cited by this paper
• Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6

  2004cited by this paper
• Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood

  2003cited by this paper
• Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

  2003cited by this paper
• Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway

  2003cited by this paper
• Immunopathogenesis of Sjögren's syndrome

  2003cited by this paper
• Cutting Edge: A Novel Toll/IL-1 Receptor Domain-Containing Adapter That Preferentially Activates the IFN-β Promoter in the Toll-Like Receptor Signaling1

  2002cited by this paper

• Modulatory effects of M3 muscarinic acetylcholine receptor on inflammatory profiles of human memory T helper cells.

  2025cites this paper
• Hydroxychloroquine enhances efferocytosis and modulates inflammation via MerTK/Gas6 signaling in a pristane-induced lupus mouse model

  2025cites this paper
• An inherited mitochondrial DNA mutation remodels inflammatory cytokine responses in macrophages and in vivo in mice

  2025cites this paper
• Design, Synthesis, and Development of Pyrazolo[1,5-a]pyrimidine Derivatives as a Novel Series of Selective PI3Kδ Inhibitors: Part II—Benzimidazole Derivatives

  2022cites this paper
• Effectiveness of anti‐interleukin‐17‐receptor antibody for hydroxychloroquine‐induced generalized pustular psoriasis in a patient with systemic lupus erythematosus

  2022cites this paper
• Inflammatory Dendritic Cells Contribute to Regulate the Immune Response in Sickle Cell Disease

  2021cites this paper
• Norcantharidin ameliorates the development of murine lupus via inhibiting the generation of IL-17 producing cells

  2021cites this paper
• Saliva and Serum Cytokine Profiles During Oral Ulceration in Behçet’s Disease

  2021cites this paper
• A Current Review on the Pathogenesis and Treatments of Vitiligo

  2020cites this paper
• Abnormal differentiation of regulatory T cells and Th17 cells induced by perinatal bisphenol A exposure in female offspring mice

  2020cites this paper
• Current Developments in the Immunology of Psoriasis

  2020cites this paper
• Gene Expression Profiling in Fibromyalgia Indicates an Autoimmune Origin of the Disease and Opens New Avenues for Targeted Therapy

  2020cites this paper
• Airways therapy of obstructive sleep apnea dramatically improves aberrant levels of soluble cytokines involved in autoimmune disease.

  2020cites this paper
• Relationships between immune gene expression and circulating cytokine levels in wild house mice

  2020cites this paper
• Cellular and molecular factors in the pathogenesis of systemic autoimmunity and comorbidities

  2019cites this paper
• Mesenchymal Stem Cells: Allogeneic MSC May Be Immunosuppressive but Autologous MSC Are Dysfunctional in Lupus Patients

  2019cites this paper
• Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity

  2019cites this paper
• IL-17 inhibition: is it the long-awaited savior for alopecia areata?

  2018cites this paper
• MicroRNA Expression Profiling in Behçet's Disease

  2018cites this paper
• Signalling pathways identified in salivary glands from primary Sjögren’s syndrome patients reveal enhanced adipose tissue development

  2018cites this paper
• Diminished CXCR5 expression in peripheral blood of patients with Sjögren's syndrome may relate to both genotype and salivary gland homing

  2018cites this paper
• Gene Expression Profiling in Behcet's Disease Indicates an Autoimmune Component in the Pathogenesis of the Disease and Opens New Avenues for Targeted Therapy

  2018cites this paper
• Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases

  2017cites this paper
• Development of de novo psoriasis during nivolumab therapy for metastatic renal cell carcinoma: immunohistochemical analyses and clinical outcome

  2017cites this paper
• Gene Expression Analysis before and after Treatment with Adalimumab in Patients with Ankylosing Spondylitis Identifies Molecular Pathways Associated with Response to Therapy

  2017cites this paper
• New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis

  2016cites this paper
• AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies

  2016cites this paper
• Milk fat globule E-8 and interleukin 17 in systemic lupus erythematosus: partners in crime?

  2016cites this paper
• A pathogenic IFNα, BLyS and IL-17 axis in Systemic Lupus Erythematosus patients

  2016cites this paper
• Cytokine-specific autoantibodies in AIRE deficiency

  2016cites this paper
• Gene Expression Profiling in Peripheral Blood Cells and Synovial Membranes of Patients with Psoriatic Arthritis

  2015cites this paper
• Auto-reactions, autoimmunity and psoriatic arthritis.

  2015cites this paper
• Acquired Idiopathic Generalized Anhidrosis: An Immunohistopathological Investigation of Peri-glands Infiltrated with Immunoreactive Cells.

  2015cites this paper
• Long-term ustekinumab therapy of psoriasis in patients with coexisting rheumatoid arthritis and Sjögren syndrome. Report of two cases and review of literature.

  2015cites this paper
• A Plasmacytoid Dendritic Cells-Type I Interferon Axis Is Critically Implicated in the Pathogenesis of Systemic Lupus Erythematosus

  2015cites this paper
• Type I interferon and T helper 17 cells co‐exist and co‐regulate disease pathogenesis in lupus patients

  2015cites this paper
• Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directions.

  2015cites this paper
• Function of the Th17/Interleukin‐17A Immune Response in Murine Lupus Nephritis

  2015cites this paper
• Targeting of type I interferon in systemic autoimmune diseases.

  2015cites this paper
• T Cell Targeted Therapies in Lupus: Do They Make Sense?

  2015cites this paper
• TH17 cells, interleukin‐17 and interferon‐ γ in patients and households contacts of leprosy with multibacillary and paucibacillary forms before and after the start of chemotherapy treatment

  2015cites this paper
• Régulation de la survie des cellules dendritiques plasmacytoïdes dans un contexte inflammatoire non viral

  2015influential citation
• CXCL13 blockade attenuates lupus nephritis of MRL/lpr mice.

  2015cites this paper
• Omission of Author Name in Article by the ACCESS Trial Group (Arthritis Rheumatol, November 2014)

  2015cites this paper
• Update on the immunobiology of Sjögren's syndrome

  2015cites this paper
• A pathogenetic role for IL-21 in primary Sjögren syndrome

  2015cites this paper
• Disturbed T Cell Signaling and Altered Th17 and Regulatory T Cell Subsets in the Pathogenesis of Systemic Lupus Erythematosus

  2015cites this paper
• Inhibition of phosphoinositide 3-kinase delta attenuates experimental autoimmune encephalomyelitis in mice.

  2015cites this paper
• Type I IFN signature in primary Sjögren’s syndrome patients

  2014cites this paper
• Allergen immunotherapy, routes of administration and cytokine networks: an update.

  2014cites this paper
• Identification of human peripheral blood monocyte derived pro-inflammatory dendritic cells

  2014cites this paper
• Type I IFN in Lupus Coexistence of Pathogenic Th17 Cells and Complement Component C5a Permits the

  2014cites this paper
• CD4(-)CD8(-) T-cells in primary Sjögren's syndrome: association with the extent of glandular involvement.

  2014cites this paper
• Cytokine expression in patients with bladder pain syndrome/interstitial cystitis ESSIC type 3C.

  2014cites this paper
• Serum level of eight cytokines in Han Chinese patients with systemic lupus erythematosus using multiplex fluorescent microsphere method

  2014cites this paper
• Rheumatic diseases and the microbiome

  2014cites this paper
• The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies.

  2014cites this paper
• Inhibition of PI3Kδ Improves Systemic Lupus in Mice

  2014cites this paper
• T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?

  2014cites this paper
• Complement Component C5a Permits the Coexistence of Pathogenic Th17 Cells and Type I IFN in Lupus

  2014cites this paper
• Too much salt inflames our body: fact or artifact?

  2014cites this paper
• IL-33 Neutralization Suppresses Lupus Disease in Lupus-Prone Mice

  2014cites this paper
• Clitocybe nuda Activates Dendritic Cells and Acts as a DNA Vaccine Adjuvant

  2013cites this paper
• Induction of Th17 Lymphocytes and Treg Cells by Monocyte-Derived Dendritic Cells in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus

  2013cites this paper
• The Cytokine and Chemokine Profiles in Patients with Hand, Foot and Mouth Disease of Different Severities in Shanghai, China, 2010

  2013cites this paper
• Immunopathogenesis of chronic obstructive pulmonary disease

  2013cites this paper
• Cytokine inhibition as a strategy for treating systemic lupus erythematosus.

  2013cites this paper
• Treating multiple sclerosis with monoclonal antibodies: a 2013 update

  2013cites this paper
• Perspectives of the relationship between IL-7 and autoimmune diseases

  2013influential citation
• Studies on Lupus Nephritis

  2013influential citation
• Comparison of Interleukin-17- Producing Cells in Different Clinical Types of Alopecia Areata

  2013cites this paper
• The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses.

  2013cites this paper
• P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/caspase 1 pathway.

  2013cites this paper
• Emerging new roles of Th17 cells

  2012cites this paper
• Immune Heterogeneity in Neuroinflammation: Dendritic Cells in the Brain

  2012cites this paper